Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: Relevance with therapeutic efficacies

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Shu, Xiao Hong ^a   Li, Hong ^a   Sun, Xiao Xin ^a   Wang, Qian ^a   Sun, Zheng ^a   Wu, Mo Li ^a   Chen, Xiao Yan ^a   Li, Chong ^a   Kong, Qing You ^a   Liu, Jia ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT3; RESVERATROL; STAT3 PROTEIN; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; SULFOTRANSFERASE 1C2; SULFOTRANSFERASE 4A1; UNCLASSIFIED DRUG; ALPHA CYANO (3,4 DIHYDROXY) N BENZYLCINNAMIDE; ALPHA-CYANO-(3,4-DIHYDROXY)-N-BENZYLCINNAMIDE; ARYL SULFOTRANSFERASE; CHAPERONE; PIAS3 PROTEIN, HUMAN; STILBENE DERIVATIVE; SULT1A1 PROTEIN, HUMAN; SULT1C2 PROTEIN, HUMAN; SULT4A1 PROTEIN, HUMAN; TYRPHOSTIN;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BRAIN CELL; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; DRUG EFFICACY; DRUG METABOLISM; DRUG TRANSFORMATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOLECULAR WEIGHT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; TUMOR CELL LINE;

RATTUS;

ANIMALS; APOPTOSIS; ARYLSULFOTRANSFERASE; CELL LINE, TUMOR; CELLS, CULTURED; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR CHAPERONES; PROTEIN INHIBITORS OF ACTIVATED STAT; RATS; STAT3 TRANSCRIPTION FACTOR; STILBENES; SULFOTRANSFERASES; TYRPHOSTINS;

EID: 80855156747     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027484     Document Type: Article

References (35)

1. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, et al. (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193.
2. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, et al. (2010) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
3. Gagliano N, Aldini G, Colombo G, Rossi R, Colombo R, et al. (2010) The potential of resveratrol against human gliomas. Anticancer Drugs 21: 140-150.
4. Yang YP, Chang YL, Huang PI, Chiou GY, Tseng LM, et al. (2011) Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. J Cell Physiol doi:10.1002/jcp.22806.
5. Filippi-Chiela EC, Villodre ES, Zamin LL, Lenz G, (2011) Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS ONE 6: e20849.
6. Bastianetto S, Dumont Y, Duranton A, Vercauteren F, Breton L, et al. (2010) Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites. PLoS One 5: e12935.
7. Tang FY, Su YC, Chen NC, Hsieh HS, Chen KS, (2008) Resveratrol inhibits migration and invasion of human breast-cancer cells. Mol Nutr Food Res 52: 683-691.
8. Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL, (2009) Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys 486: 95-102.
9. Gescher AJ, Steward WP, (2003) Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol Biomarkers Prev 12: 953-957.
10. Shu XH, Li H, Sun Z, Wu ML, Kong QY, et al. (2010) Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells. Biochem Pharmacol 79: 1516-1525.
11. Wang Q, Li H, Wang XW, Wu DC, Chen XY, et al. (2003) Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells. Neurosci Lett 351: 83-86.
12. Yu LJ, Wu ML, Li H, Chen XY, Wang Q, et al. (2008) Inhibition of STAT3 expression and signaling in resveratrol- differentiated medulloblastoma cells. Neoplasia 10: 736-744.
13. Sherry MM, Reeves A, Wu JK, Cochran BH, (2009) STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells 27: 2383-2392.
14. de la Iglesia N, Puram SV, Bonni A, (2000) STAT3 regulation of glioblastoma pathogenesis. Curr Mol Med 9: 580-590.
15. Wang DG, Hang TJ, Wu CY, Liu WY, (2005) Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS. J Chromatogr B 829: 97-106.
16. Liyou NE, Buller KM, Tresillian MJ, Elvin CM, Scott HL, et al. (2003) Localization of a brain sulfotransferase, SULT4A1, in the human and rat brain: an immunohistochemical study. J Histochem Cytochem 51: 1655-1664.
17. Salman ED, Kadlubar SA, Falany CN, (2009) Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain. Drug Metab Dispos 37: 706-709.
18. Allali-Hassani A, Pan PW, Dombrovski L, Najmanovich R, Tempel W, et al. (2007) Structural and chemical profiling of the human cytosolic sulfotransferases. PLoS Biol 5: 1063-1078.
19. Ganapathy S, Chen Q, Singh KP, Shankar S, Srivastava RK, (2010) Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor. PLoS One 5: e15627.
20. Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL, (2010) Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 54: 7-16.
21. Wenzel E, Somoza V, (2005) Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res 49: 472-481.
22. Murias M, Miksits M, Aust S, Spatzenegger M, Thalhammer T, et al. (2008) Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. Cancer Lett 261: 172-182.
23. Lancon A, Hanet N, Jannin B, Delmas D, Heydel JM, et al. (2007) Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Drug Metab Dispos 35: 699-703.
24. Urpi-Sarda M, Zamora-Ros R, Lamuela-Raventos R, Cherubini A, Jauregui O, et al. (2007) HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans. Clin Chem 53: 292-299.
25. Kotha A, Sekharam M, Cilenti L, Siddiquee K, Khaled A, et al. (2006) Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol Cancer Ther 5: 621-629.
26. Brantley EC, Benveniste EN, (2008) Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 65: 675-684.
27. Birner P, Toumangelova-Uzeir K, Natchev S, Guentchev M, (2010) STAT3 tyrosine phosphorylation influences survival in glioblastoma. J Neurooncol 100: 339-343.
28. Brantley EC, Nabors LB, Gillespie GY, Choi YH, Palmer CA, et al. (2008) Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression. Clin Cancer Res 14: 4694-4704.
29. Rödel B, Tavassoli K, Karsunky H, Schmidt T, Bachmann M, et al. (2000) The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO J 19: 5845-5855.
30. Ogata Y, Osaki T, Naka T, Iwahori K, Furukawa M, et al. (2006) Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation. Neoplasia 8: 817-825.
31. Li H, Hamou MF, de Tribolet N, Jaufeerally R, Hofmann M, et al. (1993) Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res 53: 5345-5349.
32. Keles GE, Berger MS, Srinivasan J, Kolstoe DD, Bobola MS, et al. (1995) Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol Res 7: 493-503.
33. Yang F, Van Meter TE, Buettner R, Hedvat M, Liang W, et al. (2008) Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas. Mol Cancer Ther 7: 3519-3526.
34. Lo HW, Cao X, Zhu H, Ali-Osman F, (2008) Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators. Clin Cancer Res 14: 6042-6054.
35. Bhardwaj A, Sethi G, Vadhan-Raj S, Bueso-Ramos C, Takada Y, et al. (2007) Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109: 2293-2302.